We invest in startups generating a positive impact on business.

We invest in internet and mobile technology startups.

We invest in companies led by under-represented founders, seeking significant returns.

We invest in small and medium businesses.

We invest in early-stage disruptive companies led by ambitious founders across various sectors.

We invest in technology impacting real estate, specifically proptech solutions, as a venture capital fund.

We invest across various asset classes, from venture capital to public markets and credit.

We invest in early-stage companies emerging from leading academic labs and research institutions in the field of regenerative medicine. We focus on therapies and technologies that can repair, replace, or regenerate organs, tissues, cells, and/or genes with the goal of treating the root causes of disease, rather than managing symptoms.

We invest in promising companies across various industries.

We invest in information technology companies.

We invest in information and communication technology and life sciences companies and funds.

We invest in innovative healthcare solutions.

We invest in a diverse range of opportunities.

We invest in finance.

We invest in cutting-edge technology within manufacturing, robotics, and motion control, including information technology solutions.

We invest in agnostic areas.

We invest in companies that create opportunities for stakeholders.

We invest in companies that we can support with financial and managerial expertise.

We invest in web3.

We invest broadly.